ClinicalTrialsFinder

Resectable Pancreatic Cancer Clinical Trials in Beijing, Beijing Municipality

1 recruitingBeijing, Beijing Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer

Borderline Resectable Pancreatic Cancer
Peking Union Medical College Hospital45 enrolled1 locationNCT06387810